logo-loader

Allergy Therapeutics upbeat after raising annual revenue forecasts

Published: 09:35 14 Jul 2016 BST

Manuel Llobet, chief executive at Allergy Therapeutics (LON:AGY), tells Proactive Investors revenues for the year ended June were slightly ahead of market expectations.

Llobet says the company is outperforming most competitors after the company said it had grown its market share by two percentage points to 12%.

The company expects strong revenue growth to continue for several years, it told investors.

Caledonia Mining tackles 2023 challenges with optimism for 2024 as it...

Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) chief executive Mark Learmonth tells Proactive's Stephen Gunnion the company faced a challenging 2023, primarily due to poor production in the first half of the year at its core asset, the Blanket Mine in Zimbabwe, and an underperformance...

1 hour, 32 minutes ago